Astera Labs, Inc. ALAB
364.62
4.11
1.14%
as of 25 Sep
- Market cap
- $63.7B
- P/E
- 168×
Follow ALAB
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 25.83% | 21.11% | 18.82% | 18.40% |
+8 more TTM periods Free account |
|
| 23.07% | 19.25% | 16.95% | 16.68% | ||
ROIC |
36.15% | 45.23% | 62.00% | 48.53% | |
Return on Tangible Assets |
22.99% | 19.32% | 16.59% | 15.76% | |
Average Days of Receivables |
58.45 | 49.13 | 35.62 | 21.66 | |
Free Cash Flow per Share |
1.61 | 2.01 | 1.69 | 1.37 | |
Free Cash Flow |
276.68 | 342.81 | 281.76 | 229.44 | |
Capital Expenditures |
(59.04) | (40.59) | (37.54) | (34.30) | |
Piotroski F-Score |
4.00 | 6.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
11.27% | 14.31% | 12.51% | 10.96% | |
Accounts Receivable Turnover |
11.09 | 9.79 | 13.97 | 21.18 | |
Accounts Payable Turnover |
6.99 | 5.64 | 5.98 | 8.02 | |
Inventory Turnover |
3.47 | 4.32 | 4.06 | 4.67 | |
Average Days of Payables |
65.85 | 84.73 | 74.60 | 52.99 | |
Days of Inventory on Hand |
138.93 | 91.31 | 103.86 | 106.06 | |
Tax Rate |
0.15 | (0.01) | 0.00 | 0.33 | |
Research and Development Expense of Revenue |
36.13% | 36.46% | 35.66% | 36.89% | |
Selling, General and Administrative Expense of Revenue |
16.25% | 17.17% | 19.69% | 23.77% | |
Share Based Compensation of Revenue |
16.23% | 16.63% | 18.77% | 23.08% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 1.43 | 1.46 | 1.33 | |
Depreciation/Fixed assets |
0.05 | 0.03 | (0.01) | (0.07) | |
Capex/Depreciation |
(9.33) | (14.38) | 34.04 | 7.11 | |
Revenue per Share |
6.97 | 5.87 | 5.12 | 4.32 | |
Operating CF per Share |
1.95 | 2.25 | 1.92 | 1.58 | |
Capex per Share |
(0.34) | (0.24) | (0.23) | (0.20) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.05 | |
Net Profit Margin |
30.74% | 26.72% | 25.70% | 27.50% |
Columns are period end dates